Y C Cohen
Overview
Explore the profile of Y C Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perry C, Luttwak E, Balaban R, Shefer G, Morales M, Aharon A, et al.
Blood Adv
. 2021 Aug;
5(16):3053-3061.
PMID: 34387648
Patients diagnosed with B-cell non-Hodgkin lymphoma (B-NHL), particularly if recently treated with anti-CD20 antibodies, are at risk of severe COVID-19 disease. Because studies evaluating humoral response to COVID-19 vaccine in...
2.
Reddi H, Madde P, Cohen Y, Bangio L, Breitbart E, Harats D, et al.
Genes Cancer
. 2012 Jun;
2(10):993-5.
PMID: 22701765
VB-111 is an engineered antiangiogenic adenovirus that expresses Fas-c in angiogenic blood vessels and has previously been shown to have significant antitumor activity in vitro and in vivo in Lewis...
3.
Cohen Y, Scaradavou A, Stevens C, Rubinstein P, Gluckman E, Rocha V, et al.
Bone Marrow Transplant
. 2010 May;
46(1):70-6.
PMID: 20436518
A retrospective analysis was conducted to examine factors affecting early mortality after myeloablative, single-unit cord blood transplantation (CBT) for hematological malignancies in adolescents and adults. Data were collected from the...
4.
Cohen Y, Hassin-Baer S, Olmer L, Barishev R, Goldhammer Y, Freedman L, et al.
Mult Scler
. 2000 Nov;
6(5):355-61.
PMID: 11064447
Kurtzke's EDSS remains the most widely-used measure for clinical evaluation of MS patients. However, several studies have demonstrated the limited reliability of this tool. We introduce a computerized instrument, MS-CANE...
5.
Cohen Y, Djulbegovic B, Mozes B
Arch Intern Med
. 2000 Jun;
160(11):1630-8.
PMID: 10847256
Background: No firm data are available on the natural history of idiopathic thrombocytopenic purpura (ITP) or on mortality rates or frequency of major bleeding episodes associated with this condition. The...
6.
Cohen Y, Rubin H, Freedman L, Mozes B
J Clin Epidemiol
. 1999 Oct;
52(11):1031-6.
PMID: 10526996
Predictive models have been used to identify factors that may prolong hospital length of stay (LOS). However, because predictors of LOS are collinear, the proportion of variance associated with each...
7.
Cohen Y, Olmer L, Mozes B
Int J Qual Health Care
. 1996 Feb;
8(1):67-73.
PMID: 8680819
Purpose: To find outlier centers in different aspects of quality of care by comparing two different outcomes and adjusting to case mix in benign prostatic hypertrophy (BPH) patients undergoing prostatectomy....
8.
Mozes B, Cohen Y, Olmer L, Shabtai E
J Urol
. 1996 Jan;
155(1):191-6.
PMID: 7490831
Purpose: The impact of prostatectomy on quality of life was assessed in patients with benign prostatic hypertrophy (BPH) who were classified according to the expected benefit from surgical intervention. The...